139 related articles for article (PubMed ID: 20701601)
41. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.
Pichler H; Möricke A; Mann G; Teigler-Schlegel A; Niggli F; Nebral K; König M; Inthal A; Krehan D; Dworzak MN; Janousek D; Harbott J; Schrappe M; Gadner H; Strehl S; Haas OA; Panzer-Grümayer R; Attarbaschi A;
Br J Haematol; 2010 Apr; 149(1):93-100. PubMed ID: 20067563
[TBL] [Abstract][Full Text] [Related]
42. RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia.
Podgornik H; Debeljak M; Zontar D; Cernelc P; Prestor VV; Jazbec J
Cancer Genet Cytogenet; 2007 Oct; 178(1):77-81. PubMed ID: 17889714
[TBL] [Abstract][Full Text] [Related]
43. Cytogenetics and molecular genetics of acute lymphoblastic leukemia.
Harrison CJ; Foroni L
Rev Clin Exp Hematol; 2002 Jun; 6(2):91-113; discussion 200-2. PubMed ID: 12196211
[TBL] [Abstract][Full Text] [Related]
44. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
Chessels JM; Swansbury GJ; Reeves B; Bailey CC; Richards SM
Br J Haematol; 1997 Oct; 99(1):93-100. PubMed ID: 9359508
[TBL] [Abstract][Full Text] [Related]
45. Molecular processes involved in B cell acute lymphoblastic leukaemia.
Malouf C; Ottersbach K
Cell Mol Life Sci; 2018 Feb; 75(3):417-446. PubMed ID: 28819864
[TBL] [Abstract][Full Text] [Related]
46. Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.
Kulis J; Sędek Ł; Słota Ł; Perkowski B; Szczepański T
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011285
[TBL] [Abstract][Full Text] [Related]
47. Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia.
Akkari YMN; Bruyere H; Hagelstrom RT; Kanagal-Shamanna R; Liu J; Luo M; Mikhail FM; Pitel BA; Raca G; Shago M; Shao L; Smith LR; Smolarek TA; Yenamandra A; Baughn LB
Cancer Genet; 2020 May; 243():52-72. PubMed ID: 32302940
[TBL] [Abstract][Full Text] [Related]
48. Outcomes in Pediatric Acute Lymphoblastic Leukemia-A Single-Center Romanian Experience.
Alecsa MS; Moscalu M; Trandafir LM; Ivanov AV; Rusu C; Miron IC
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33333966
[TBL] [Abstract][Full Text] [Related]
49. A population-based cytogenetic study of adults with acute lymphoblastic leukemia.
Moorman AV; Chilton L; Wilkinson J; Ensor HM; Bown N; Proctor SJ
Blood; 2010 Jan; 115(2):206-14. PubMed ID: 19897583
[TBL] [Abstract][Full Text] [Related]
50. Adult Acute Lymphoblastic Leukemia: A Genetic Overview and Application to Clinical Practice.
Jacobson S; Tedder M; Eggert J
Clin J Oncol Nurs; 2016 Dec; 20(6):E147-E154. PubMed ID: 27857258
[TBL] [Abstract][Full Text] [Related]
51. Childhood Early T Cell Precursor Acute Lymphoblastic Leukaemia with t(12;17) (p13;q21) Translocation - A Rare Entity or Part of ETP/Myeloid Mixed Phenotype Acute Leukaemia.
Krishnan Y; S G; Joy A; S SP; S RJ; S S
Gulf J Oncolog; 2022 Sep; 1(40):78-82. PubMed ID: 36448075
[TBL] [Abstract][Full Text] [Related]
52. [Acute lymphoblastic leukemia: pathophysiology and current therapy].
Imai K
Rinsho Ketsueki; 2017; 58(5):460-470. PubMed ID: 28592761
[TBL] [Abstract][Full Text] [Related]
53. New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia.
Starý J; Zuna J; Zaliova M
F1000Res; 2018; 7():. PubMed ID: 30345005
[TBL] [Abstract][Full Text] [Related]
54. BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays.
Wallace J; Zhou Y; Usmani GN; Reardon M; Newburger P; Woda B; Pihan G
Leukemia; 2003 Jul; 17(7):1411-3. PubMed ID: 12835732
[No Abstract] [Full Text] [Related]
55. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.
Ryan SL; Peden JF; Kingsbury Z; Schwab CJ; James T; Polonen P; Mijuskovic M; Becq J; Yim R; Cranston RE; Hedges DJ; Roberts KG; Mullighan CG; Vora A; Russell LJ; Bain R; Moorman AV; Bentley DR; Harrison CJ; Ross MT
Leukemia; 2023 Mar; 37(3):518-528. PubMed ID: 36658389
[TBL] [Abstract][Full Text] [Related]
56. New genetics and diagnosis of childhood B-cell precursor acute lymphoblastic leukemia.
Harrison C
Pediatr Rep; 2011 Jun; 3 Suppl 2(Suppl 2):e4. PubMed ID: 22053280
[TBL] [Abstract][Full Text] [Related]
57. Machine Learning Based Analysis of Relations between Antigen Expression and Genetic Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia.
Kulis J; Wawrowski Ł; Sędek Ł; Wróbel Ł; Słota Ł; van der Velden VHJ; Szczepański T; Sikora M
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566407
[TBL] [Abstract][Full Text] [Related]
58. Intrachromosomal Amplification of Chromosome 21 in Childhood Acute Lymphoblastic Leukemia: Study of 3 Cases.
Mroczkowska A; Lejman M
Case Rep Oncol; 2021; 14(1):592-598. PubMed ID: 33976639
[TBL] [Abstract][Full Text] [Related]
59. Mutant PRPS1: a new therapeutic target in relapsed acute lymphoblastic leukemia.
Mullighan CG
Nat Med; 2015 Jun; 21(6):553-4. PubMed ID: 26046573
[No Abstract] [Full Text] [Related]
60. Predicting outcome in childhood acute lymphoblastic leukemia using gene expression profiling: prognostication or protocol selection?
Catchpoole D; Guo D; Jiang H; Biesheuvel C
Blood; 2008 Feb; 111(4):2486-7; author reply 2487-8. PubMed ID: 18263786
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
